Dysregulation of signal transduction pathways can contribute to various diseases. Aberrant activation or inhibition of signaling pathways can disrupt normal cellular processes, leading to conditions such as cancer, metabolic disorders, immune disorders, neurological disorders, and cardiovascular diseases. Understanding and targeting these dysregulated pathways are important for developing therapeutic interventions.